Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATCHS: GIK in Non-Diabetic Abdominal Surgery
NCT06624956Phase 4Completed
- Sponsor
- University of Washington
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin, sodium potassium magnesium calcium and glucose injection and potassium chloride in hyperglycemia (2 arms), sponsored by University of Washington. Primary endpoints: 30-day Clinical NSQIP-defined serious adverse events, Patient compliance/burden at 1 day and 3 more. Started Sep 2024; status: completed.
02
Drugs
human insulinsodium potassium magnesium calcium and glucose injectionpotassium chloride
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT06624956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06624956.